Display options
Share it on

PLoS One. 2016 Sep 27;11(9):e0163806. doi: 10.1371/journal.pone.0163806. eCollection 2016.

The Prevalence of Vitiligo: A Meta-Analysis.

PloS one

Yuhui Zhang, Yunfei Cai, Meihui Shi, Shibin Jiang, Shaoshan Cui, Yan Wu, Xing-Hua Gao, Hong-Duo Chen

Affiliations

  1. Department of Dermatology, No. 1 Hospital of China Medical University, Shenyang, 110001, China.
  2. Department of Dermatology, No. 1 Hospital of Dalian Medical University, DaLian, 116011, China.

PMID: 27673680 PMCID: PMC5038943 DOI: 10.1371/journal.pone.0163806

Abstract

OBJECTIVE: To conduct a meta-analysis assessing the prevalence of vitiligo.

METHODS: Literatures that reported prevalence rates of vitiligo were identified using EMBASE, PubMed, the Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang database and Weipu database for the period from inception to May 2016. We performed stratified analyses on possible sources of bias, including areas difference, years of publication, gender and age. Publication bias was assessed with Egger's test method.

RESULTS: A total of 103 studies were eligible for inclusion. The pooled prevalence of vitiligo from 82 population- or community-based studies was 0.2% (95%CI: 0.1%-0.2%) and from 22 hospital-based studies was 1.8% (95%CI: 1.4%-2.1%). A relatively high prevalence of vitiligo was found in Africa area and in female patients. For population- or community-based studies, the prevalence has maintained at a low level in recent 20 years and it has increased with age gradually. For hospital-based studies, the prevalence has showed a decreased trend from 60s till now or from young to old. No significant publication bias existed in hospital-based studies (t = 0.47, P = 0.643), while a significant publication bias existed in population- or community-based studies (t = 2.31, P = 0.026).

CONCLUSION: A relatively high prevalence of vitiligo was found in Africa area and in female patients. The prevalence has maintained at a low level in recent years. It showed an inverse trend with age increment in population- or community-based studies and hospital-based studies.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

  1. Int J Dermatol. 2014 May;53(5):609-16 - PubMed
  2. Genet Epidemiol. 1985;2(1):71-8 - PubMed
  3. Int J Dermatol. 2007 Jan;46(1):47-51 - PubMed
  4. Bol Med Hosp Infant Mex. 1977 Jan-Feb;34(1):137-61 - PubMed
  5. Acta Derm Venereol. 2013 Jan;93(1):62-5 - PubMed
  6. Lepr Rev. 2005 Jun;76(2):144-6 - PubMed
  7. Nat Rev Dis Primers. 2015 Jun 04;1:15011 - PubMed
  8. J Cosmet Dermatol. 2008 Sep;7(3):164-8 - PubMed
  9. Int J Dermatol. 2005 Jan;44(1):7-11 - PubMed
  10. Indian Dermatol Online J. 2014 Nov;5(Suppl 1):S6-8 - PubMed
  11. Pediatr Dermatol. 2003 Nov-Dec;20(6):470-3 - PubMed
  12. J Formos Med Assoc. 2008 Jan;107(1):21-9 - PubMed
  13. Dermatologica. 1985;170(2):65-8 - PubMed
  14. Dermatology. 2013;227(4):311-5 - PubMed
  15. Int J Dermatol. 1997 Sep;36(9):650-2 - PubMed
  16. Yonsei Med J. 2015 May;56(3):719-25 - PubMed
  17. Acta Derm Venereol. 1980;60(4):352-3 - PubMed
  18. Vital Health Stat 11. 1978 Nov;(212):i-v, 1-72 - PubMed
  19. Dermatologica. 1981;163(1):78-93 - PubMed
  20. J Am Acad Dermatol. 2007 Jun;56(6):933-8 - PubMed
  21. Pediatr Dermatol. 1989 Mar;6(1):39-42 - PubMed
  22. Arthritis Rheum. 2002 Jul;46(7):1851-6 - PubMed
  23. Int J Dermatol. 2014 Aug;53(8):956-8 - PubMed
  24. Allergol Immunopathol (Madr). 2011 Nov-Dec;39(6):356-61 - PubMed
  25. Lancet. 2015 Jul 4;386(9988):74-84 - PubMed
  26. Indian J Dermatol Venereol Leprol. 1997 Jan-Feb;63(1):22-5 - PubMed
  27. J Dermatol. 2011 Apr;38(4):310-20 - PubMed
  28. Arch Intern Med. 1979 Nov;139(11):1295-7 - PubMed
  29. Int J Dermatol. 2000 Jan;39(1):18-20 - PubMed
  30. BMC Public Health. 2010 Dec 16;10:765 - PubMed
  31. Saudi Med J. 2006 Feb;27(2):227-34 - PubMed
  32. Pigment Cell Res. 2003 Jun;16(3):208-14 - PubMed
  33. Ceylon Med J. 2000 Sep;45(3):123-8 - PubMed
  34. Dermatologica. 1991;183(4):239-45 - PubMed
  35. Br J Dermatol. 1999 May;140(5):891-6 - PubMed
  36. J Eur Acad Dermatol Venereol. 2011 Jan;25(1):105-9 - PubMed
  37. Int J Dermatol. 2007 Oct;46 Suppl 2:35-8 - PubMed
  38. Arch Dermatol. 2003 Dec;139(12):1614-9; discussion 1619 - PubMed
  39. Int J Dermatol. 1996 Sep;35(9):633-9 - PubMed
  40. Arch Dermatol. 2008 Mar;144(3):310-6 - PubMed
  41. J Eur Acad Dermatol Venereol. 2015 Jul;29(7):1362-9 - PubMed
  42. Int J Dermatol. 2005 Jan;44(1):29-33 - PubMed
  43. West Afr J Med. 2009 Mar;28(2):118-21 - PubMed
  44. Med J Aust. 1979 Jun 16;1(12):569-70 - PubMed
  45. Int J Dermatol. 2004 Jan;43(1):31-6 - PubMed
  46. Pediatr Dermatol. 2012 Jan-Feb;29(1):114-5 - PubMed
  47. Pediatr Dermatol. 1999 Jan-Feb;16(1):6-11 - PubMed
  48. J Med Assoc Thai. 2000 Sep;83(9):999-1004 - PubMed
  49. J Dermatol. 2005 Jul;32(7):557-64 - PubMed
  50. Dermatology. 1994;189(2):129-32 - PubMed
  51. Acta Derm Venereol. 1980;60(5):415-23 - PubMed
  52. J Dermatol. 2008 Jul;35(7):413-8 - PubMed
  53. J Dermatol. 1999 Oct;26(10):653-7 - PubMed
  54. Dermatology. 2004;208(1):38-42 - PubMed
  55. Int J Dermatol. 2003 Nov;42(11):887-92 - PubMed
  56. Indian J Med Res. 1973 Jan;61(1):145-54 - PubMed
  57. Arch Dermatol. 1977 Jan;113(1):47-52 - PubMed
  58. Int J Dermatol. 2012 Oct;51(10):1180-5 - PubMed
  59. J Am Acad Dermatol. 2011 Sep;65(3):473-91 - PubMed
  60. Br J Dermatol. 2008 Feb;158(2):334-8 - PubMed
  61. Dan Med Bull. 1964 Feb;11:1-7 - PubMed
  62. Hepatology. 2002 Dec;36(6):1439-45 - PubMed
  63. J Indian Med Assoc. 1998 Aug;96(8):245-6 - PubMed

Publication Types